Gene therapy has come a long way to get where it is today but there is still much to learn and investigate. Host Adam Rutherford speaks to a line-up of experts about the vital role of clinical trials and the unique challenges facing gene therapy and rare disease patients.Featuring guests:Brenda Cooperstone, Senior Vice President, Chief Development Officer, Rare Disease, PfizerEmily Crossley, Chief Executive Officer, Duchenne UKErik Paulsen, Chair, Institute for Gene TherapiesProfessor John Rasko, Clinical Haematologist & Trial Investigator, University of SydneySimone Boselli, Director, Public Affairs, EURORDISSuneet Varma, Global President, Rare Disease, Pfizer  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ver todos los episodios